Amino Acids

, Volume 36, Issue 4, pp 739–746

TIG3: a regulator of type I transglutaminase activity in epidermis

  • Richard L. Eckert
  • Michael T. Sturniolo
  • Ralph Jans
  • Catherine A. Kraft
  • Haibing Jiang
  • Ellen A. Rorke
Review Article

Abstract

Keratinocytes undergo a process of terminal cell differentiation that results in the construction of a multilayered epithelium designed to produce a structure that functions to protect the body from dehydration, abrasion and infection. These protective properties are due to the production of a crosslinked layer of protein called the cornified envelope. Type I transglutaminase (TG1), an enzyme that catalyzes the formation of ε-(γ-glutamyl)lysine bonds, is the key protein responsible for generation of the crosslinks. The mechanisms that lead to activation of transglutaminase during terminal differentiation are not well understood. We have identified a protein that interacts with TG1 and regulates its activity. This protein, tazarotene-induced gene 3 (TIG3), is expressed in the differentiated layers of the epidermis and its expression is associated with transglutaminase activation and cornified envelope formation. We describe a novel mechanism whereby TIG3 regulates TG1 activity.

Keywords

Transglutaminase TIG3 Keratinocyte differentiation Calcium RIG1 H-rev 107 tumor suppressor 

Abbreviations

TG1

Transglutaminase type 1

TIG3

Tazarotene-induced gene 3

FC

Fluorescein cadaverine

References

  1. Aeschlimann D, Koeller MK, Allen-Hoffmann BL, Mosher DF (1998) Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primers. J Biol Chem 273:3452–3460Google Scholar
  2. Ahvazi B, Steinert PM (2003) A model for the reaction mechanism of the transglutaminase 3 enzyme. Exp Mol Med 35:228–242PubMedGoogle Scholar
  3. Anantharaman V, Aravind L (2003) Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol 4:R11PubMedCrossRefGoogle Scholar
  4. Bickenbach JR, Greer JM, Bundman DS, Rothnagel JA, Roop DR (1995) Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. J Invest Dermatol 104:405–410PubMedCrossRefGoogle Scholar
  5. Bok D, Ruiz A, Yaron O, Jahng WJ, Ray A, Xue L, Rando RR (2003) Purification and characterization of a transmembrane domain-deleted form of lecithin retinol acyltransferase. Biochemistry 42:6090–6098PubMedCrossRefGoogle Scholar
  6. Candi E, Melino G, Mei G, Tarcsa E, Chung SI, Marekov LN, Steinert PM (1995) Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein. J Biol Chem 270:26382–26390PubMedCrossRefGoogle Scholar
  7. Candi E, Tarcsa E, Idler WW, Kartasova T, Marekov LN, Steinert PM (1999) Transglutaminase cross-linking properties of the small proline-rich 1 family of cornified cell envelope proteins. Integration with loricrin. J Biol Chem 274:7226–7237Google Scholar
  8. Candi E, Oddi S, Terrinoni A, Paradisi A, Ranalli M, Finazzi-Agro A, Melino G (2001) Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro. J Biol Chem 276:35014–35023PubMedCrossRefGoogle Scholar
  9. Candi E, Oddi S, Paradisi A, Terrinoni A, Ranalli M, Teofoli P, Citro G, Scarpato S, Puddu P, Melino G (2002) Expression of transglutaminase 5 in normal and pathologic human epidermis. J Invest Dermatol 119:670–677PubMedCrossRefGoogle Scholar
  10. Candi E, Paradisi A, Terrinoni A, Pietroni V, Oddi S, Cadot B, Jogini V, Meiyappan M, Clardy J, Finazzi-Agro’ A, Melino G (2004) Transglutaminase 5 is regulated by guanine/adenine nucleotides. Biochem J 381:313–319PubMedCrossRefGoogle Scholar
  11. Chakravarty R, Rice RH (1989) Acylation of keratinocyte transglutaminase by palmitic and myristic acids in the membrane Anchorage region. J Biol Chem 264:625–629PubMedGoogle Scholar
  12. Deucher A, Nagpal S, Chandraratna RA, Di Sepio D, Robinson NA, Dashti SR, Eckert RL (2000) The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol 17:1195–1203PubMedGoogle Scholar
  13. DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RA, Nagpal S (1998) Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci USA 95:14811–14815PubMedCrossRefGoogle Scholar
  14. Dubbink HJ, de Waal L, van Haperen R, Verkaik NS, Trapman J, Romijn JC (1998) The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization. Genomics 51:434–444PubMedCrossRefGoogle Scholar
  15. Duvic M, Helekar B, Schulz C, Cho M, DiSepio D, Hager C, DiMao D, Hazarika P, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman SM, Chandraratna RA, Robinson NA, Deucher A, Eckert RL, Nagpal S (2000) Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 6:3249–3259PubMedGoogle Scholar
  16. Duvic M, Ni X, Talpur R, Herne K, Schulz C, Sui D, Ward S, Joseph A, Hazarika P (2003) Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol 121:902–909PubMedCrossRefGoogle Scholar
  17. Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF (1993) Involucrin–structure and role in envelope assembly. J Invest Dermatol 100:613–617PubMedCrossRefGoogle Scholar
  18. Eckert RL, Crish JF, Robinson NA (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397–424PubMedGoogle Scholar
  19. Eckert RL, Sturniolo MT, Broome AM, Ruse M, Rorke EA (2005) Transglutaminase function in epidermis. J Invest Dermatol 124:481–492PubMedCrossRefGoogle Scholar
  20. Efimova T, Broome AM, Eckert RL (2004) Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex. Mol Cell Biol 24:8167–8183PubMedCrossRefGoogle Scholar
  21. Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27:534–539PubMedCrossRefGoogle Scholar
  22. Green H (1980) The keratinocyte as differentiated cell type. Harvey Lect 74:101–139PubMedGoogle Scholar
  23. Grenard P, Bates MK, Aeschlimann D (2001) Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J Biol Chem 276:33066–33078PubMedCrossRefGoogle Scholar
  24. Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature’s biological glues. Biochem J 368:377–396PubMedCrossRefGoogle Scholar
  25. Higuchi E, Chandraratna RA, Hong WK, Lotan R (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22:4627–4635PubMedCrossRefGoogle Scholar
  26. Huang SL, Shyu RY, Yeh MY, Jiang SY (2000) Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells. Mol Cell Endocrinol 159:15–24PubMedCrossRefGoogle Scholar
  27. Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SP, Ponec M, Bon A, Lautenschlager S, Schorderet DF, Hohl D (1995) Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 267:525–528PubMedCrossRefGoogle Scholar
  28. Jahng WJ, Xue L, Rando RR (2003) Lecithin retinol acyltransferase is a founder member of a novel family of enzymes. Biochemistry 42:12805–12812PubMedCrossRefGoogle Scholar
  29. Jans R, Sturniolo MT, Eckert RL (2008) Localization of the TIG3 transglutaminase interaction domain and demonstration that the amino-terminal region is required for TIG3 function as a keratinocyte differentiation regulator. J Invest Dermatol 128:517–529PubMedGoogle Scholar
  30. Jarnik M, Simon MN, Steven AC (1998) Cornified cell envelope assembly: a model based on electron microscopic determinations of thickness and projected density. J Cell Sci 111(Pt 8):1051–1060PubMedGoogle Scholar
  31. Jiang SY, Wu MS, Chen LM, Hung MW, Lin HE, Chang GG, Chang TC (2005) Identification and characterization of the retinoic acid response elements in the human RIG1 gene promoter. Biochem Biophys Res Commun 331:630–639PubMedCrossRefGoogle Scholar
  32. Kim HC, Idler WW, Kim IG, Han JH, Chung SI, Steinert PM (1991) The complete amino acid sequence of the human transglutaminase K enzyme deduced from the nucleic acid sequences of cDNA clones. J Biol Chem 266:536–539PubMedGoogle Scholar
  33. Kim IG, McBride OW, Wang M, Kim SY, Idler WW, Steinert PM (1992) Structure and organization of the human transglutaminase 1 gene. J Biol Chem 267:7710–7717PubMedGoogle Scholar
  34. Kim IG, Lee SC, Lee JH, Yang JM, Chung SI, Steinert PM (1994) Structure and organization of the human transglutaminase 3 gene: evolutionary relationship to the transglutaminase family. J Invest Dermatol 103:137–142PubMedCrossRefGoogle Scholar
  35. Kim SY, Chung SI, Yoneda K, Steinert PM (1995) Expression of transglutaminase 1 in human epidermis. J Invest Dermatol 104:211–217PubMedCrossRefGoogle Scholar
  36. Kruszewski FH, Hennings H, Yuspa SH, Tucker RW (1991) Regulation of intracellular free calcium in normal murine keratinocytes. Am J Physiol 261:C767–C773PubMedGoogle Scholar
  37. Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140–156PubMedCrossRefGoogle Scholar
  38. Lorand L, Barnes N, Bruner-Lorand JA, Hawkins M, Michalska M (1987) Inhibition of protein cross-linking in Ca2+-enriched human erythrocytes and activated platelets. Biochemistry 26:308–313PubMedCrossRefGoogle Scholar
  39. Lotz K, Kellner T, Heitmann M, Nazarenko I, Noske A, Malek A, Gontarewicz A, Schafer R, Sers C (2005) Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mechanisms. Int J Cancer 116:894–902PubMedCrossRefGoogle Scholar
  40. Menon GK, Grayson S, Elias PM (1985) Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 84:508–512PubMedCrossRefGoogle Scholar
  41. Michel S, Bernerd F, Jetten AM, Floyd EE, Shroot B, Reichert U (1992) Expression of keratinocyte transglutamine mRNA revealed by in situ hybridization. J Invest Dermatol 98:364–368PubMedCrossRefGoogle Scholar
  42. Nemes Z, Steinert PM (1999) Bricks and mortar of the epidermal barrier. Exp Mol Med 31:5–19PubMedGoogle Scholar
  43. Ou CC, Hsu SC, Hsieh YH, Tsou WL, Chuang TC, Liu JY, Kao MC (2008) Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells. Carcinogenesis 29:299–306PubMedCrossRefGoogle Scholar
  44. Petit E, Huber M, Rochat A, Bodemer C, Teillac-Hamel D, Muh JP, Revuz J, Barrandon Y, Lathrop M, de Prost Y, Hohl D, Hovnanian A (1997) Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity. Eur J Hum Genet 5:218–228PubMedGoogle Scholar
  45. Phillips MA, Stewart BE, Qin Q, Chakravarty R, Floyd EE, Jetten AM, Rice RH (1990) Primary structure of keratinocyte transglutaminase. Proc Natl Acad Sci USA 87:9333–9337PubMedCrossRefGoogle Scholar
  46. Phillips MA, Stewart BE, Rice RH (1992) Genomic structure of keratinocyte transglutaminase. Recruitment of new exon for modified function. J Biol Chem 267:2282–2286PubMedGoogle Scholar
  47. Phillips MA, Qin Q, Mehrpouyan M, Rice RH (1993) Keratinocyte transglutaminase membrane anchorage: analysis of site-directed mutants. Biochemistry 32:11057–11063PubMedCrossRefGoogle Scholar
  48. Polakowska R, Herting E, Goldsmith LA (1991) Isolation of cDNA for human epidermal type I transglutaminase. J Invest Dermatol 96:285–288PubMedCrossRefGoogle Scholar
  49. Rice RH, Rong XH, Chakravarty R (1990) Proteolytic release of keratinocyte transglutaminase. Biochem J 265:351–357PubMedGoogle Scholar
  50. Rice RH, Mehrpouyan M, O’Callahan W, Parenteau NL, Rubin AL (1992) Keratinocyte transglutaminase: differentiation marker and member of an extended family. Epithelial Cell Biol 1:128–137PubMedGoogle Scholar
  51. Ruse M, Lambert A, Robinson N, Ryan D, Shon KJ, Eckert RL (2001) S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry 40:3167–3173PubMedCrossRefGoogle Scholar
  52. Sers C, Emmenegger U, Husmann K, Bucher K, Andres AC, Schafer R (1997) Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev 107 in tumor cell lines and experimental tumors. J Cell Biol 136:935–944PubMedCrossRefGoogle Scholar
  53. Siefring GE Jr, Apostol AB, Velasco PT, Lorand L (1978) Enzymatic basis for the Ca2+-induced cross-linking of membrane proteins in intact human erythrocytes. Biochemistry 17:2598–2604PubMedCrossRefGoogle Scholar
  54. Simon M, Green H (1984) Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 36:827–834PubMedCrossRefGoogle Scholar
  55. Steven AC, Steinert PM (1994) Protein composition of cornified cell envelopes of epidermal keratinocytes. J Cell Sci 107:693–700PubMedGoogle Scholar
  56. Sturniolo MT, Dashti SR, Deucher A, Rorke EA, Broome AM, Chandraratna RA, Keepers T, Eckert RL (2003) A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. J Biol Chem 278:48066–48073PubMedCrossRefGoogle Scholar
  57. Sturniolo MT, Chandraratna RA, Eckert RL (2005) A novel transglutaminase activator forms a complex with type 1 transglutaminase. Oncogene 24:2963–2972PubMedCrossRefGoogle Scholar
  58. Tarcsa E, Marekov LN, Andreoli J, Idler WW, Candi E, Chung SI, Steinert PM (1997) The fate of trichohyalin. Sequential post-translational modifications by peptidyl-arginine deiminase and transglutaminases. J Biol Chem 272:27893–27901PubMedCrossRefGoogle Scholar
  59. Tarcsa E, Candi E, Kartasova T, Idler WW, Marekov LN, Steinert PM (1998) Structural and transglutaminase substrate properties of the small proline-rich 2 family of cornified cell envelope proteins. J Biol Chem 273:23297–23303PubMedCrossRefGoogle Scholar
  60. Tsai FM, Shyu RY, Jiang SY (2006) RIG1 inhibits the Ras/mitogen-activated protein kinase pathway by suppressing the activation of Ras. Cell Signal 18:349–358PubMedCrossRefGoogle Scholar
  61. Tsai FM, Shyu RY, Jiang SY (2007) RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. Cell Signal 19:989–999PubMedCrossRefGoogle Scholar
  62. Xue L, Rando RR (2004) Roles of cysteine 161 and tyrosine 154 in the lecithin-retinol acyltransferase mechanism. Biochemistry 43:6120–6126PubMedCrossRefGoogle Scholar
  63. Yang JM, Ahn KS, Cho MO, Yoneda K, Lee CH, Lee JH, Lee ES, Candi E, Melino G, Ahvazi B, Steinert PM (2001) Novel mutations of the transglutaminase 1 gene in lamellar ichthyosis. J Invest Dermatol 117:214–218PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Richard L. Eckert
    • 1
    • 2
    • 3
  • Michael T. Sturniolo
    • 1
    • 2
    • 3
  • Ralph Jans
    • 1
    • 2
    • 3
  • Catherine A. Kraft
    • 1
    • 2
    • 3
  • Haibing Jiang
    • 1
    • 2
    • 3
  • Ellen A. Rorke
    • 2
    • 3
    • 4
  1. 1.Department of Biochemistry and Molecular BiologyUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Department of DermatologyUniversity of Maryland School of MedicineBaltimoreUSA
  3. 3.Greenebaum Cancer CenterUniversity of Maryland School of MedicineBaltimoreUSA
  4. 4.Department of Microbiology and ImmunologyUniversity of Maryland School of MedicineBaltimoreUSA

Personalised recommendations